NCT03087409View on ClinicalTrials.gov

High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up

CompletedOBSERVATIONAL

Enrollment

885

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

July 1, 2018

Study Completion Date

July 1, 2018

Conditions

Breast Cancer Female

Trial Locations (10)

Unknown

Academic Medical Center, Amsterdam

The Netherlands Cancer Institute, Amsterdam

VU University Medical Center, Amsterdam

Medisch Spectrum Twente, Enschede

University Medical Center Groningen, Groningen

Leiden University Medical Center, Leiden

Maastricht University Medical Center, Maastricht

Radboud University Medical Center, Nijmegen

Erasmus Medical Center, Rotterdam

University Medical Center Utrecht, Utrecht

All Listed Sponsors

collaborator

The Netherlands Cancer Institute

OTHER

lead

University Medical Center Groningen

OTHER

NCT03087409 - High-dose Chemotherapy With Hematopoietic Stem-cell Rescue for High-risk Breast Cancer: Long-term Follow-up | Biotech Hunter | Biotech Hunter